股票代码：002734 股票简称：利民股份 公告编号：2025-090 利民控股集团股份有限公司 关于召开 2025 年第二次临时股东大会的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 利民控股集团股份有限公司（以下简称"公司"）于 2025 年 10 月 31 日在《中 国证券报》《证券时报》及巨潮资讯网(www.cninfo.com.cn)上刊登了《公司关于 召开 2025 年第二次临时股东大会的通知》（公告编号：2025-087），本次股东大 会将采取现场投票与网络投票相结合的方式召开，现再次将会议相关事项提示公 告如下： 一、会议召开的基本情况 公司第六届董事会第十次会议决定于 2025 年 11 月 17 日召开 2025 年第二次临 时股东大会，具体内容如下： 1、会议召集人：公司董事会 2、本次股东大会的召开符合有关法律、行政法规、部门规章、规范性文件和 公司《章程》的相关规定。 3、会议召开时间： （1）现场会议召开时间：2025 年 11 月 17 日（星期一）14:30。 （2）网络投票时间：2025 年 11 月 17 日（ ...

Market Overview - The agricultural chemical sector declined by 1.12% on November 14, with Limin Co. leading the drop [1] - The Shanghai Composite Index closed at 3990.49, down 0.97%, while the Shenzhen Component Index closed at 13216.03, down 1.93% [1] Stock Performance - Lianhua Technology (002250) saw a significant increase of 10.00%, closing at 15.40 with a trading volume of 1.476 million shares [1] - Other notable gainers included Baiao Chemical (603360) with a 5.01% increase and ST Huifeng (002496) with a 3.23% increase [1] - Limin Co. (002734) experienced the largest decline at 5.05%, closing at 18.98 with a trading volume of 337,000 shares [2] Capital Flow - The agricultural chemical sector experienced a net outflow of 1.047 billion yuan from institutional investors, while retail investors saw a net inflow of 786 million yuan [2] - The data indicates that while institutional investors withdrew funds, retail investors were actively buying into the sector [2] Individual Stock Capital Flow - Lianhua Technology had a net inflow of 289 million yuan from institutional investors, but a net outflow of 162 million yuan from speculative funds [3] - Other companies like Xingfa Group (600141) and Dongfang Iron Tower (002545) also showed varied capital flows, with institutional and retail investors behaving differently [3]

Core Viewpoint - Limin Co., Ltd. has experienced significant stock price fluctuations and strong financial performance in 2023, with a notable increase in revenue and net profit, indicating potential growth opportunities in the agricultural chemicals sector [1][2]. Group 1: Stock Performance - As of November 14, Limin's stock price decreased by 2.00% to 19.59 CNY per share, with a trading volume of 1.52 billion CNY and a turnover rate of 1.92%, resulting in a total market capitalization of 8.699 billion CNY [1]. - Year-to-date, Limin's stock price has increased by 153.66%, with a 6.58% rise over the last five trading days and a 5.04% increase over the last 20 days, although it has declined by 9.52% over the last 60 days [1]. - The company has appeared on the "龙虎榜" (a trading board for stocks with significant trading activity) six times this year, with the most recent appearance on June 20, where it recorded a net purchase of 24.78 million CNY [1]. Group 2: Financial Performance - For the period from January to September 2025, Limin achieved a revenue of 3.599 billion CNY, representing a year-on-year growth of 7.62%, while the net profit attributable to shareholders reached 390 million CNY, marking a substantial increase of 661.66% [2]. - The company's main business revenue composition includes agricultural fungicides (50.57%), insecticides (30.51%), veterinary drugs (9.34%), herbicides (8.47%), and other products [1]. Group 3: Shareholder Information - As of October 31, the number of Limin's shareholders increased to 62,500, reflecting a rise of 12.55%, while the average number of circulating shares per shareholder decreased by 11.15% to 6,444 shares [2]. Group 4: Dividend Information - Since its A-share listing, Limin has distributed a total of 919 million CNY in dividends, with 321 million CNY distributed over the past three years [3].

Core Viewpoint - The price of chlorosulfonic acid has surged rapidly, with a recent increase of 13.72% to 1765 RMB/ton, marking a cumulative rise of 23.5% in November and over 35% since early August, indicating a significant trend in the electrolyte raw material market [1][3]. Group 1: Price Trends - Chlorosulfonic acid is a key raw material for lithium bis(fluorosulfonyl)imide (LiFSI), which is increasingly seen as a substitute for lithium hexafluorophosphate (LiPF6) due to its superior technical specifications [3]. - The price of lithium hexafluorophosphate has reached 130,000 RMB/ton, diminishing its cost advantage over LiFSI [3]. - The price increase of chlorosulfonic acid is partly driven by a significant rise in sulfur prices, which have exceeded 3500 RMB/ton, with an annual increase of over 130% [3]. Group 2: Stock Market Reactions - On November 13, the A-share lithium battery industry chain saw a broad increase, particularly in stocks related to electrolytes, with companies like Furui Co. experiencing six consecutive trading limits [4]. - Several stocks, including Fuxiang Pharmaceutical, Huasheng Lithium Battery, and Haike New Source, also hit the 20% trading limit [6]. - Chlorosulfonic acid-related stocks such as Sanyou Chemical, Shilong Industrial, and Kaisheng New Materials experienced rapid price increases, with some reaching trading limits [6][9]. Group 3: Company Capacities and Developments - Kaisheng New Materials is a global leader in chlorosulfonic acid production, with an annual capacity of 150,000 tons, holding over 26% of the global market share [9]. - Jinhua Industrial has an existing capacity of 80,000 tons for chlorosulfonic acid, with a project to build an additional 100,000 tons underway [9]. - Sanyou Chemical is progressing on a project to produce 40,000 tons of chlorosulfonic acid, expected to be completed in Q4 of this year [9]. - Companies like Taihe Technology and Yongtai Technology are also expanding their production capacities for lithium bis(fluorosulfonyl)imide, with planned capacities of 20,000 tons and 67,000 tons per year, respectively [10][11].

Group 1 - The core viewpoint of the news is that Limin Co., Ltd. has shown significant stock performance, with a year-to-date increase of 154.18% and a recent rise of 2.03% in stock price [1] - As of November 13, the stock price reached 19.63 yuan per share, with a total market capitalization of 8.717 billion yuan [1] - The company has seen a net inflow of main funds amounting to 3.6133 million yuan, with large orders contributing significantly to the trading volume [1] Group 2 - Limin Co., Ltd. operates in the basic chemical industry, specifically in agricultural chemical products, including pesticides [2] - The company reported a revenue of 3.599 billion yuan for the period from January to September 2025, reflecting a year-on-year growth of 7.62%, while the net profit attributable to shareholders increased by 661.66% to 390 million yuan [2] - The company has a shareholder base of 62,500, which has increased by 12.55% compared to the previous period [2] Group 3 - Since its A-share listing, Limin Co., Ltd. has distributed a total of 919.8 million yuan in dividends, with 321 million yuan distributed over the past three years [3]

Core Insights - The agricultural chemical sector experienced a decline of 0.94% on November 12, with Chengxing Co. leading the drop [1] - The Shanghai Composite Index closed at 4000.14, down 0.07%, while the Shenzhen Component Index closed at 13240.62, down 0.36% [1] Stock Performance Summary - Baiao Chemical (603360) saw a closing price of 34.59, with an increase of 4.22% and a trading volume of 182,100 shares, totaling a transaction value of 613 million yuan [1] - Chengxing Co. (600078) reported a significant decline of 10.00%, closing at 12.06 with a trading volume of 807,000 shares and a transaction value of 979 million yuan [2] - The overall agricultural chemical sector had a net outflow of 1.573 billion yuan from major funds, while retail investors contributed a net inflow of 1.245 billion yuan [2][3] Fund Flow Analysis - Major funds showed a net inflow of 34.63 million yuan into Luohua Technology (600691), while retail investors had a net outflow of 28.86 million yuan [3] - Li Min Co. (002734) experienced a net inflow of 26.16 million yuan from major funds, but a net outflow of 34.85 million yuan from retail investors [3] - Baiao Chemical (603360) had a net inflow of 11.19 million yuan from major funds, with retail investors showing a net outflow of 8.34 million yuan [3]

Core Viewpoint - Limin Co., Ltd. has experienced significant stock price fluctuations and strong financial performance, with a notable increase in revenue and net profit year-on-year, indicating potential growth in the agricultural chemicals sector [1][2]. Financial Performance - As of October 31, Limin Co., Ltd. achieved a revenue of 3.599 billion yuan for the period from January to September 2025, representing a year-on-year growth of 7.62% [2]. - The company's net profit attributable to shareholders reached 390 million yuan, showing a remarkable increase of 661.66% compared to the previous year [2]. - The company has distributed a total of 919 million yuan in dividends since its A-share listing, with 321 million yuan distributed over the past three years [3]. Stock Market Activity - On November 12, Limin Co., Ltd.'s stock price fell by 2.05% to 18.63 yuan per share, with a trading volume of 33.1959 million yuan and a turnover rate of 0.44%, resulting in a total market capitalization of 8.273 billion yuan [1]. - The stock has increased by 141.23% year-to-date, with a 2.93% rise over the last five trading days, but has seen a decline of 5.43% over the past 20 days and 16.98% over the past 60 days [1]. - The company has appeared on the "Dragon and Tiger List" six times this year, with the most recent occurrence on June 20, where it recorded a net purchase of 24.7786 million yuan [1]. Business Overview - Limin Co., Ltd. is located in Xinyi Economic Development Zone, Jiangsu Province, and was established on December 17, 1996, with its shares listed on January 27, 2015 [1]. - The company's main business involves the research, production, and sales of agricultural fungicides, with revenue composition as follows: fungicides 50.57%, insecticides 30.51%, veterinary drugs 9.34%, herbicides 8.47%, and others 0.96% [1].

Group 1 - The company is currently in the preliminary stage of its new energy project, specifically regarding the production of lithium bis(fluorosulfonyl)imide (LiFSI) [2] - Investors are inquiring about the production timeline and expected output of LiFSI [2]

股票代码：002734 股票简称：利民股份 公告编号：2025-089 利民控股集团股份有限公司 关于为子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、担保情况概述 利民控股集团股份有限公司（以下简称"公司"））分别于 2025 年 4 月 17 日、 2025 年 5 月 9 日召开第六届董事会第四次会议、2024 年度股东大会，审议通过了 《关于 2025 年度为子公司提供担保额度预计的议案》。同意公司为河北威远药业 有限公司（以下简称"威远药业"）在 2025 年度合计不超过人民币 11,000 万元的 银行债务提供连带责任保证担保。有效期自公司 2024 年度股东大会审议通过后至 公司 2025 年度股东大会审议相关担保额度议案之日止。具体内容详见公司于 2025 年 4 月 18 日在指定信息披露媒体《证券时报》《中国证券报》和巨潮资讯网 （http://www.cninfo.com.cn）披露的《公司关于 2025 年度为子公司提供担保额 度预计的公告》（公告编号：2025-032）。 二、担保进展情况 2025 年 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [6] Core Insights - The company achieved significant year-on-year growth in performance, with revenue of 3.6 billion yuan in the first three quarters of 2025, up 7.6% year-on-year, and a net profit attributable to shareholders of 390 million yuan, up 661.7% year-on-year [4][12] - The growth is attributed to increased sales and prices of key products, improved gross margins, and increased investment income from affiliated companies [13] - The company is strategically positioning itself in AI and synthetic biology, with plans for the first fluorinated insecticide to be mass-produced in 2025 and collaborations to enhance pesticide development efficiency [14][15] Financial Performance Summary - For the first three quarters of 2025, the company reported revenue of 3.6 billion yuan, a net profit of 390 million yuan, and a non-recurring net profit of 380 million yuan, showing substantial increases of 7.6%, 661.7%, and 1014.9% respectively [4][12] - In Q3 2025, revenue was 1.15 billion yuan, up 9.7% year-on-year but down 7.6% quarter-on-quarter, with a net profit of 120 million yuan, reflecting a year-on-year increase of 522.3% but a quarter-on-quarter decrease of 24.6% [12][13] - The company expects revenue growth of 21%, 9%, and 8% for 2025, 2026, and 2027 respectively, with net profit growth of 528%, 12%, and 12% for the same years [15][16] Market Position and Strategy - The company is focusing on synthetic biology and AI applications to enhance its product development capabilities, which is expected to open new growth avenues [14][15] - The strategic partnership with Green Xin Nuo Bio aims to develop peptide-based biopesticides, indicating a move towards industrialization of synthetic biology strategies [14] - The company has also adjusted prices for key products in response to raw material cost increases and market demand, indicating proactive market strategies [13]